OKYO Pharma Ltd (NASDAQ:OKYO) said it has been informed that Panetta Partners Limited, an entity in which the company’s executive chairman Gabriele Cerrone has a beneficial interest, has acquired 210,000 of OKYO Pharma’s ordinary shares on the Nasdaq, bringing his total holding to 10,382,677 shares.
The Markets by Proactive
Go to Proactive Australia
Proactive’s Australian coverage continues on .com